BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW)

CUSIP: 10778Y112

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / *W EXP 02/26/202
Total 13F shares
176,057
Share change
+25,384
Total reported value
$12,658
Price per share
$0.08
Number of holders
6
Value change
+$1,076
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 10778Y112?
CUSIP 10778Y112 identifies BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) as of Q2 2025

As of 30 Jun 2025, BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 176,057 shares. The largest 6 holders included Redmond Asset Management, LLC, TWO SIGMA SECURITIES, LLC, ARMISTICE CAPITAL, LLC, HRT FINANCIAL LP, Newbridge Financial Services Group, Inc., and UBS Group AG. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.